Peer Review History
| Original SubmissionFebruary 28, 2021 |
|---|
|
PONE-D-21-06676 Estimation of mean Population salt intakes using Spot Urine samples and its association to BMI, Hypertension, raised Blood Sugar and Blood Lipids: Findings from Non-communicable Disease Risk Factors (STEPS) Survey 2019 in Nepal PLOS ONE Dear Dr. Dhimal, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Shyam Sundar Budhathoki, MBBS, MD, MPH Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works, some of which you are an author. - https://www.bmj.com/content/bmj/368/bmj.m315.full.pdf - https://onlinelibrary.wiley.com/doi/full/10.1111/jch.12778 We would like to make you aware that copying extracts from previous publications, especially outside the methods section, word-for-word is unacceptable. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications. Please revise the manuscript to rephrase the duplicated text, cite your sources, and provide details as to how the current manuscript advances on previous work. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work. We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study aims to determine the population mean of salt intakes and its correlates using 2019 STEPS survey data in Nepal. The research question is adequately motivated. However, there are some concerns that authors need to address to improve the quality of the manuscript. Comments • The title and objectives of the study are not consistent. • Title needs some improvement. For example, while hypertension and raised blood sugar indicate a direction, the authors did not mention about BMI and lipid level similarly. Please revise the title. Also, use hypercholesterolemia instead of high cholesterol level. • It is highly preferable to use consistent terms throughout the whole manuscript. For instance, raised blood sugar is used in the title but there is no indication of such variables in the result, except diabetes. • The authors mentioned that the equation from INTERSALT was developed using a large heterogenous population sample. Do the authors mean by the term “heterogenous” that the equation can be applied to the Nepalese population? • The authors also explicitly mentioned the equation INTERSALT for southern Europe. If this is the case, there would be at least some anthropometric differences between these and Nepalese population? For example, considering BMI and age adjustment to the equation would seem to be more appropriate instead of using the original equation. • In Table 2, the prevalence of salt intake > 5 g was higher in women than in man, whereas that of salt intake > 10 g was reversed, higher in man than in women. Please discuss this. • As the authors rightly discussed that people with history of hypertension may be aware of their hypertensive status and likely to reduce salt intake. This can also be linked to behavioral and lifestyle choices. That’s why salt intake is higher in men as women are more likely to take care of themselves. Likewise, BMI can also be attributed by lifestyle choices and hence, by salt intake. Therefore, there is no clear indication of exposure and outcome pathway in this model. • What are the clinical implications of the study beyond the assessment of population salt intake and validation of equation in Nepalese population? • Conclusion should be based on the study findings. For instance, the study’s results did not present the lifestyle modification and its importance on health indicators. It is also not a finding of the study that “population-based salt reduction strategies are cost-effective and cost-saving in most of the settings for prevention of non-communicable diseases.”. Please revise the conclusion. • References should be relevant and up-to-date. Please try to reduce the number of references. • in Table 4, there is no need to report R squared or adjusted R squared without presenting all models. Remove the last two columns. • If p-value is 0.000, indicate using “<0.001” in Table 3 and 4. Reviewer #2: General Comments: This study used data collected from spot urine tests to estimate population-level salt intake in Nepal, and to assess the relationship of salt intake with various anthropometric and metabolic factors. Data was derived from the well-known STEPS Survey and incorporated a large, nationally-representative study population. The study has potentially very relevant and important findings for future intervention for NCDs in Nepal. However, I have a number of concerns and/or queries with some of the information being presented in its current form which I would like the authors to address. Firstly, in the introduction, there needs to be more emphasis as to why salt intake corresponds to various anthropometric and metabolic variables, so as to build a strong rationale for the investigation into these relationships in this study. Particular attention should be paid to the variables that are subsequently stated in the study aim. Greater clarity is needed over the statistical methods employed in this study, as at times important data appear to have conflicting findings depending on the analyses used. See specific comments in results section. Tables need revising for better clarity on the reporting of data, particularly concerning SI units. The discussion covered the major points raised in the study. However, clear assessment of this section is hampered at this time by outstanding questions over the presentation (and conflicts) of results using ANOVA and multivariable/multivariate regression. Important limitations were highlighted in the discussion, which was good to see, as well as the study strengths. I feel you could make the strengths of this study seem more impactful though, by concentrating less on it being the “first” study to show these findings and more on the relevance, i.e., that it is a Nationwide population study, that incorporated individuals of all regions, caste, sex and age, and thus the study findings are highly generalisable for Nepal. This is an important step in determining future interventions to reduce salt intake among Nepalese peoples. Although I commend the authors on a generally well-written manuscript, there were several grammatical errors noted throughout and, particularly as PLOS One do not copy edit, the authors should ensure that the written language is reviewed and modified accordingly. Specific Comments: Introduction: Line 87: You state equations have been investigated in several studies but provide no indication of the validity or reliability of these methods. Please expand further by discussing the strengths, limitations and validity and reliability of using estimation methods. Line 88-89: The grammar isn’t quite right here – I’m not sure what you’re meaning. Line 91-: You need to be clearer on your aim/purpose. Use future tense (what you aim to do) rather than past tense (what you have already done). Methods: Line 102: Was the sample of 925 per province selected in advance, i.e., was this a target? If so, why was this particular number selected? Was there a margin, or mechanism in place in case you weren’t able to recruit exactly this number (i.e., it seems as though only this precise number of households were contacted, but what if they refused to participate in the survey)? Line 104: Could you provide further clarity on what constitutes a primary sample unit. How were these identified? Line 107: Please clarify what you mean when you say ‘using the android tablet’. Is this specifically in relation to randomly sampling one adult in each household, or something else? In what way was the android tablet used? Line 110 onwards: If relevant, please clarify that the field research assistants led/facilitated all or which parts of the data collection (i.e., steps 1-3?). Please also clarify the stated background experience, i.e., presumably, researchers were required to have one of the stated backgrounds rather than expecting to have experience in all of these fields? Line 113: Further detail is needed on the interview process. How was this conducted? Did the researchers ask questions and complete the answers for the participants, or were they just ‘on-hand’ to answer any questions if they arose whilst the participants completed the questionnaires? Were consistent methods applied throughout Nepal? Line 114: How was height measured? All other measures have procedures stated. Line 118: Manufacturer details missing Line 126: Typo – ‘sport’ urine testing Line 131: How were the urine sample containers provided to participants, i.e., were they delivered in person by the researchers the night before the interview? What is the relevance of the QR code in this context? Were all participants requested to submit a urine sample? Line 132: Was a minimum level of urine required/specified for collection? Line 136: Please clarify what you mean by ‘nearly located places’ Line 140-141: I’m not sure what you mean by this sentence. Please clarify how you managed pregnant women with regards to these measurements. Line 141-143: Please clarify your rationale for excluding participants above and below these criterion values. Line 173-174: What do you mean by the salt and non-salt participants? Line 178-179: More detail is needed on the statistical tests in relation to specific variables of interest (e.g., how many factor ANOVA, what groups, etc?), and also clear rationale for using the selected methods (e.g., why both ANOVA and multivariable/multivariate regression?). Were follow-up tests employed where differences were noted? This needs more clarity here and in the results section. Line 180: The terms multivariate and multivariable regression are used interchangeably in this paper. Please clarify the statistical methods employed. You may wish to refer to this article for reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518362/ Line 185: This implies only verbal study information was provided to prospective participants. Was written information not supplied also? If so, were participants given ample time to consider their involvement / seek advice from others / ask any questions to the study team? Please clarify these points. Results: Line 201: Why was one PSU “dropped”? Line 203: An incorrect percentage is reported for the sample attained at Step 3. Line 204: You refer to consent for the urine test. Was consent for this aspect sought independently from ‘general’ consent for participation? If so, this needs clarifying earlier in the methods section. Line 231: Clarify what you mean by ‘SE’ here. Why are you reporting standard error (assuming this is what you mean) and not standard deviation? Line 247: Is this per day? Line 249-250: If this result is not significant in table 3, then reasonably you cannot suggest an association between education level and salt intake based upon your data. Line 251: As above, this result was non-significant in table 3. It is misleading to suggest that wealth is impacting on salt intake based upon this data. However, I note in table 4 that a significant result is reported between the highest and lowest wealth index. Therefore, you need to be clear what the information in this paragraph is referring to, e.g., table 3 or table 4 data. Line 255: What does “(0.19)” refer to following BMI at this point? Lines 255-257: Data in table 3 shows that there was no significant difference between hypertensive and normotensive participants, yet here you state that salt intake differed. Again, is this related to data in table 3 or table 4? NB. It appears that data in tables 3 and 4 are conflicting at times, for certain variables, and this means that the reader may be confused by the presentation of your findings at this stage of the manuscript. Further justification and explanation is warranted as to why the specific data analyses have been used, and the merit of each method discussed. Table 1: a) A number of measures are reported in this table that are not mentioned in the methods section. Please refer to all assessed measures in the methods section. b) Mean ± SD age should not be reported in column 1. Consider incorporating a ‘total’ column that would allow this data to be presented more appropriately. c) Data for age for men and women are confusing with the units used. SI units for age need to be reported. The use of ‘n’ implies that you’re reporting 42.2 males, when in fact I believe you’re reporting that the mean age for males was 42.2 y. Please clarify. d) Similarly, SI units need to be reported for age ranges. e) SI units in column headings suggest that percentages will be reported in parentheses, but this is only done for the first factor, age. All other values are missing. f) How has residence been categorised? What are the definitions / criteria used to determine whether someone resides in a metropolitan/sub-metropolitan, municipality, or rural area? This information needs to be included within the methods section. g) Check table for formatting inconsistencies (e.g., bold) h) How has wealth been categorised? What are the definitions / criteria used to determine the lowest, second, middle, fourth, highest category of wealth? This information needs to be included within the methods section. i) Consider splitting the sociodemographic information from the anthropometric and metabolic variables within this table, either by using two separate tables or at least sub-dividing the data – particularly as these measures have been clearly delineated into Step 1, 2 and 3 of data collection. j) Reporting of anthropometric measures is confusing, again due to the inconsistent way units are being reported. I suggest that you remove the reference to mean ± SD from column 1, where used, and replace this with the appropriate SI units for each variable, e.g., height (cm), weight (kg), etc. Then, where applicable, use an asterisk on the data in column 1 where values will be being reported as mean ± SD in columns 2 and 4, and write a simple sentence explaining this underneath the table. Use this method for other variables, where applicable. Units should then be removed from the column headings of columns 2 and 4. k) Waist circumference is reported but not hip circumference, which was stated in the methods section. This needs to be included. I would also like to see the waist to hip ratio calculated for ease of comparison across studies. l) It is unclear what values are being reported in columns 2 and 4 for the sub-categories of BMI. Please clarify. m) What do you mean by “BP (high)”? These data need clarifying, and all abbreviations for blood pressure need defining at first use. n) Please clarify what you mean by “people measured to be hypertensive on treatment”. Is data reported an absolute number? What do you mean by ‘treatment’, e.g., pharmacotherapy, lifestyle management, etc? If pharmacotherapy, were differing medication / regimes documented? Further details are needed on this in the methods section. o) Please clarify your variable “Diabetes mellitus”. Is this Type 2, specifically, or all diagnoses of diabetes mellitus? Units need clarifying. p) What do you mean by “cholesterols (high)”? What type of cholesterol was measured? Further detail needed in the methods section. q) What do you mean by “Ever had a heart attack or chest pain from heart disease or stroke”? This question is confusing. How would people know that a symptom of chest pain was a result of heart disease, and what is the link here with stroke? Further clarity is needed in the methods section on this aspect. Table 2: a) Line 1, column 1 appears out of line. b) Values reported for salt intake greater than 10% above the WHO recommendation differ in the table (31%) compared to what is stated in the paragraph above and abstract (48.9%). The latter value is reported in the table for potassium intake. Please clarify these data. Also, data reported in a table should not be reported in written text, to avoid duplication. c) Standard error for total sodium/potassium ratio has been omitted. Table 3: a) SI units need to be reported. Discussion: Line 263: I’m not sure that I agree with this assertion. I do not feel that the primary aim of this study was to evaluate the capacity of spot urine samples for estimating mean population salt intake in Nepal. One of your aims was to estimate population salt intake using spot urine samples; you did not provide an “in depth evaluation” of this method in this study, however. 265-268: Make it clear here if you are referring to data in your study or elsewhere. Line 280: Why might the spot urine sample be providing lower values than 24h urine measurements? You have made the comparison on methods and introduced a discrepancy in the findings, but do not provide any reasoned argument as to why this might be or whether one method might be more valid or reliable? Please comment. Line 305: You state this finding is “not surprising”, as it has been evidenced before in a previous study, but why might salt increase be decreasing with advancing age? Line 313: Was salt intake “low” or lower in those with higher education level? To my knowledge, they still had higher salt intake than the recommended level. Line 318: Is there any suggestion as to why these provinces might be consuming more salt than others? It seems the underlying reasons for this were not assessed in this study, but perhaps there is evidence elsewhere that could provide insight, or maybe this might be a proposed area for future research? Line 368: I do not disagree with this statement, but it is pitched as if your study has demonstrated this fact, when actually no cost-effectiveness analyses have been incorporated. Consider revising this. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-21-06676R1 Estimation of mean population salt intakes using spot urine samples and associations with body mass index, hypertension, raised blood sugar and hypercholesterolemia: Findings from Non-communicable Disease Risk Factors (STEPS) Survey 2019 in Nepal PLOS ONE Dear Dr. Dhimal, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Detailed comments from the reviewer can be found in the attached PDF as annotations. In addition to the comments, please revise the manuscript for academic English and grammar, if possible with the help of a native user of English. Please submit your revised manuscript by Sep 17 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Shyam Sundar Budhathoki Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: The key finding of this research is mean salt intake, process of data collection, discuss spot vs 24 hours more effectively, practicality of such test in developing country context and how this finding can inform public health measures in Nepal. I also think just discussing significant association with gender, obesity and others is enough; no need to stress about lack of association of salt intake with hypertension or diabetes (or identifying the need for RCT). I see a lot of scope for improvement before this paper can be considered for publication. I have provided comments within the pdf paper as comments. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Estimation of mean population salt intakes using spot urine samples and associations with body mass index, hypertension, raised blood sugar and hypercholesterolemia: Findings from STEPS Survey 2019, Nepal PONE-D-21-06676R2 Dear Dr. Dhimal, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Shyam Sundar Budhathoki Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-21-06676R2 Estimation of mean population salt intakes using spot urine samples and associations with body mass index, hypertension, raised blood sugar and hypercholesterolemia: Findings from STEPS Survey 2019, Nepal Dear Dr. Dhimal: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. PLOS Manuscript Reassignment Staff Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .